CURE’s lymphoma cancer page is a go-to resource for oncology news and updates in the world of lymphoma cancer Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in lymphoma cancer.

Latest News

The FDA approved Monjuvi with Revlimid and Rituxan for R/R follicular lymphoma: © stock.adobe.com.
FDA Approves Monjuvi With Revlimid and Rituxan for Follicular Lymphoma

June 18th 2025

The FDA approved Monjuvi with Revlimid and Rituxan for R/R follicular lymphoma after it showed significantly longer progression-free survival vs placebo.

Karen Cohn is a retired middle school special education teacher who was diagnosed with follicular lymphoma in July 2020. Catch up on all of Karen's blogs here!
When Cancer and COVID Collide: The Diagnosis That Changed It All

June 17th 2025

Image of hands.
From Patient to Researcher: It’s Not All About the Cure

June 14th 2025

The ADC zilovertamab vedotin plus Rituxan and chemo showed an ORR of 56.3% in relapsed/refractory DLBCL: © stock.adobe.com.
Zilovertamab Vedotin Plus Chemo Combo Shows Responses in R/R DLBCL

June 9th 2025

The first patient has been dosed in the phase 3 TERZO trial of Copiktra for R/R nodal T-follicular helper cell lymphoma: © stock.adobe.com.
TERZO Trial Doses First Patient With Copiktra in Rare T-Cell Lymphoma

June 9th 2025